CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

445 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2019.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 388 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46.4M shares of 50.5M outstanding shares and own 91.98% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.28M shares), BlackRock Inc. (4.61M shares), AQR CAPITAL MANAGEMENT LLC (2.01M shares), FMR LLC (1.56M shares), RENAISSANCE TECHNOLOGIES LLC (1.46M shares), WELLS FARGO & COMPANY/MN (1.24M shares), STATE STREET CORP (1.15M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.13M shares), TimesSquare Capital Management, LLC (1.01M shares), and Bank of New York Mellon Corp (961K shares).
This table shows the top 388 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.